Anika gets another no from the FDA; Suture express sues Cardinal for $200M;

Conversation on Twitter :

 @FierceMedDev: Industry groups urge Congress to delay device tax. Story | Follow @FierceMedDev

@MarkHFierce: Research at Columbia proposes the use of a prenatal genetic test as standard of care--it's much more comprehensive. Item | Follow @MarkHFierce

 @DamianFierce: In case you missed it, we rounded up some industry reaction to the final medical device tax regs. Story | Follow @DamianFierce

> Anika Therapeutics ($ANIK) loses again: The FDA upheld its earlier non-approvable decision for the company's Monovisc PMA. Monovisc is a hyaluronic viscosupplement injection designed to treat small synovial joint pain, and it's already approved in Europe. Release

> Suture Express, a specialty supplier of sutures and other surgical supplies, filed a $200 million antitrust lawsuit against Cardinal Health and Owens & Minor, alleging that the wholesale distributors of medical and surgical supplies unfairly prevent their customers from using specialty suppliers. Release

> Volcano ($VOLC) is looking to raise $400 million in convertible senior notes due in 2017. Item

> Bunnell is recalling its Life Pulse High-Frequency Ventilator Patient Circuits, warning that they can overheat and send smoke into the humidifier cartridge. More

> Thermedx in Ohio hopes to raise $5 million in the coming year to support expansion centered around its fluid management surgical device. Story

> Derma Sciences ($DSCI), a medical device and pharmaceutical company focused on wound care, is pursuing a public offering to raise money, in part, for clinical development programs. Release

> Johnson & Johnson's ($JNJ) ex-head of medical devices and diagnostics is now chairman of the board at EOS imaging, and will help the orthopedic medical imaging company pursue international expansion. Release

Biotech News

 @FierceBiotech: Eli Lilly touts antibody that reverses symptom of Alzheimer's. News | Follow @FierceBiotech

@JohnCFierce: Biotech upstart Moderna nails down $40M for bold RNA idea. Article | Follow @JohnCFierce

 @RyanMFierce: FDA is on track to increase new drug approvals again. But is it enough? Story (sub. req.) | Follow @RyanMFierce

> FDA matches most new drug approvals in years in 2012; Is it enough? Report

> Against tough odds, Lundbeck touts high-stakes R&D end game. Story

> Biotech upstart Moderna nails down $40M for bold RNA idea. Article

Pharma News

@FiercePharma: Teva investors want new CEO Jeremy Levin to say he has their back in next week's analyst presentation. News | Follow @FiercePharma

> EU's top court backs antitrust fight in ruling against AstraZeneca. Report

> Another pharma free speech case hits U.S. appeals court. Story

Vaccines News

 @AlisonBFierce: FhCMB lands up to $9.9M from NIH for anthrax vaccine research. More | Follow @AlisonBFierce

> Flu season arrives a month early. Item

> DARPA tackles the DNA vaccine. Article

> Protein Sciences expands flu vaccine operations to Pfizer site. More

> Altravax lands $3.45M from NIH for HIV vaccine research. News

> Sanofi Pasteur nabs Menactra expansion in Canada. Story

Pharma Manufacturing News

> Sun setting on Sunovion Canadian API plant. Article

> Cargo theft law puts target on organized crime. News

> Lilly taps Strides, Agila for cancer med manufacturing. Story

> FDA registration deadline looms for generic drugmakers. Report

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.